A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly

Monique B Nilsson1, Huiying Sun1, Jacqulyne Robichaux1

  • 1Departments of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Insights

Acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is driven by the YAP/FOXM1 axis, promoting multidrug resistance. Targeting this axis and spindle assembly checkpoint (SAC) proteins offers new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is a significant clinical challenge, particularly when driven by EGFR-independent mechanisms like epithelial-to-mesenchymal transition (EMT).
  • Understanding the molecular drivers of this resistance is crucial for developing effective treatment strategies.

Purpose of the Study:

  • To identify the molecular mechanisms underlying EGFR TKI resistance mediated by EMT.
  • To investigate the role of the yes-associated protein (YAP) and forkhead box protein M1 (FOXM1) axis in this resistance.
  • To explore potential therapeutic vulnerabilities associated with this resistance phenotype.

Main Methods:

  • Integrated transcriptomic, proteomic, and drug screening approaches were employed.
  • Analysis of spindle assembly checkpoint (SAC) protein abundance in resistant cells.
  • Evaluation of patient specimens from EGFR-mutant lung cancer.

Main Results:

  • Activation of the YAP/FOXM1 axis was identified as a driver of EMT-associated EGFR TKI resistance.
  • EGFR TKI resistance was linked to broad multidrug resistance and increased abundance of SAC proteins (PLK1, Aurora kinases, survivin, KSP).
  • EGFR TKI-resistant cells showed vulnerability to SAC inhibitors, and high FOXM1 expression correlated with SAC protein expression and worse outcomes in patients.

Conclusions:

  • The YAP/FOXM1 axis is a central regulator of EMT-associated EGFR TKI resistance.
  • The YAP/FOXM1 axis and SAC components represent therapeutic vulnerabilities for targeting multidrug-resistant phenotypes.
  • Targeting the YAP/FOXM1-SAC pathway may overcome resistance to EGFR TKIs.

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.5K
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K